Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
25.26
+0.34 (1.36%)
Mar 6, 2026, 4:00 PM EST
SHA:688739 Market Cap
SHA:688739 has a market cap or net worth of 10.40 billion as of March 9, 2026. Its market cap has decreased by -3.67% in one year.
Market Cap
10.40B
Enterprise Value
5.35B
Revenue
1.39B
Ranking
n/a
PE Ratio
76.67
Stock Price
25.26
Market Cap Chart
Since October 28, 2021, SHA:688739's market cap has decreased from 33.32B to 10.40B, a decrease of -68.77%. That is a compound annual growth rate of -23.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 10.40B | -1.79% |
| Dec 31, 2025 | 10.59B | -0.17% |
| Dec 31, 2024 | 10.61B | -21.62% |
| Dec 29, 2023 | 13.54B | 6.87% |
| Dec 30, 2022 | 12.67B | -60.04% |
| Dec 31, 2021 | 31.70B | -4.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurisco Pharmaceutical | 10.37B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.66B |
| Chengdu Easton Biopharmaceuticals | 10.10B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.70B |
| HitGen | 10.83B |
| Chengzhi | 10.85B |
| Chongqing Genrix Biopharmaceutical | 9.84B |
| Bio-Thera Solutions | 9.37B |